BiotechTube
Epigenica

Epigenica

Stockholm, Sweden· Est.
epigenica.se
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Epigenica is a Stockholm-based biotech company pioneering high-throughput, multiplexed epigenetic profiling. Its patented EpiFinder™ platform, powered by hmqChIP-seq and LACODE barcoding technology, enables simultaneous analysis of up to 8 epigenetic markers across 24 samples from low-input materials, including plasma. This positions the company to address significant bottlenecks in epigenetics research and biomarker discovery for diseases like cancer. Epigenica is currently commercializing its first product kits and appears to be a privately-held, pre-revenue or early-revenue platform technology company.

Genetics & Genomics

Technology Platform

EpiFinder™ platform: A patented, first-in-class multiplexed quantitative ChIP-seq (hmqChIP-seq) technology combined with proprietary LACODE barcoding. It enables high-throughput, simultaneous profiling of up to 8 epigenetic marks across 24 samples from low-input materials, including liquid biopsy.

Opportunities

The primary opportunity lies in capturing share in the epigenetics research tools market by solving key throughput and cost limitations.
A major growth vector is the nascent but rapidly expanding field of liquid biopsy epigenomics, where EpiFinder™ cNUC enables non-invasive discovery of disease biomarkers for oncology and other areas.

Risk Factors

Key risks include commercialization challenges in adopting a novel platform within the research community, potential future competition from large life science tools companies, and financial sustainability as a private, early-revenue company scaling its operations.

Competitive Landscape

Epigenica competes with providers of traditional low-throughput ChIP-seq reagents and services (e.g., Diagenode, Active Motif, CST) and emerging NGS-based epigenetic assay providers. Its primary differentiation is the combination of high-plex, high-throughput, and quantitative data from low-input/liquid biopsy samples, positioning it in a unique niche.

More companies in Diagnostics & Precision Medicine →More companies in Sweden →